About Enzo Life Sciences

Enzo Life Sciences, Inc. is a subsidiary of Enzo Biochem, Inc. organized to lead in the development, production, marketing, and sales of innovative life science research reagents worldwide based on over 30 years of successful experience in building strong international market recognition, implementing outstanding operational capabilities, and establishing a state-of-the-art electronic information and ordering marketplace.

Enzo Life Sciences, Inc. is a recognized leader in labeling and detection technologies across research and diagnostic markets. A strong portfolio of labeling probes and dyes provides life science environments tools for target identification/validation and high content analysis via gene expression analysis, nucleic acid detection, protein biochemistry and detection, molecular biology, and cellular analysis.

Now incorporating the skills, experience and products of ALEXIS® Biochemicals, acquired in 2007, and BIOMOL® International, acquired in 2008, the Enzo® Life Sciences brand now provides 25 years of business experience in the supply of research biochemicals and biologicals “Enabling Discovery in Life Science™”.

Facts about Enzo Life Sciences
  • Focus : Distributor
  • Employees: 1-10
  • Industry : Laboratory analysis / Laboratory measurement technology

Here you will find Enzo Life Sciences GmbH

See the theme worlds for related content

Topic world Antibodies

Antibodies are specialized molecules of our immune system that can specifically recognize and neutralize pathogens or foreign substances. Antibody research in biotech and pharma has recognized this natural defense potential and is working intensively to make it therapeutically useful. From monoclonal antibodies used against cancer or autoimmune diseases to antibody-drug conjugates that specifically transport drugs to disease cells - the possibilities are enormous

View topic world

Topic world Antibodies

Antibodies are specialized molecules of our immune system that can specifically recognize and neutralize pathogens or foreign substances. Antibody research in biotech and pharma has recognized this natural defense potential and is working intensively to make it therapeutically useful. From monoclonal antibodies used against cancer or autoimmune diseases to antibody-drug conjugates that specifically transport drugs to disease cells - the possibilities are enormous